Taken together, these studies demonstrate the existence of a Wnt5a/ROR1–YAP/TAZ feedback loop that modulates the CSC phenotype, tumor progression, metastasis and, ultimately, drug resistance. The gene discussed is WNT5A; the disease is neoplasm.